Clinical Trials
257
Active:14
Completed:18
Trial Phases
6 Phases
Early Phase 1:3
Phase 1:18
Phase 2:121
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (207 trials with phase data)• Click on a phase to view related trials
Phase 2
121 (58.5%)Not Applicable
50 (24.2%)Phase 1
18 (8.7%)Phase 3
14 (6.8%)Early Phase 1
3 (1.4%)Phase 4
1 (0.5%)A Randomized, Two-cohort, Prospective Phase II Clinical Study of the Second-line Treatment of Advanced Biliary System Tumors With Liposomal Irinotecan (II) Combination Regimen
Not Applicable
Not yet recruiting
- Conditions
- Biliary Tract Cancer (BTC)
- Interventions
- Drug: Liposomal irinotecan+5-FU/LV+LenvatinibDrug: NALIRI
- First Posted Date
- 2025-08-01
- Last Posted Date
- 2025-08-01
- Target Recruit Count
- 90
- Registration Number
- NCT07099794
- Locations
- 🇨🇳
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
A Prospective, Single-Center, Randomized Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of Nab-Paclitaxel Combined With Cisplatin and Sintilimab in Neoadjuvant Treatment of Locally Advanced Cervical Cancer
Not Applicable
Not yet recruiting
- Conditions
- Cervical Carcinoma
- Interventions
- Radiation: Concurrent chemo-radiotherapy
- First Posted Date
- 2025-07-28
- Last Posted Date
- 2025-07-28
- Target Recruit Count
- 180
- Registration Number
- NCT07088731
- Locations
- 🇨🇳
Department of Gynecological Oncology, Beijing, China
Hypofractionated vs Conventional RT After Prosthetic Breast Reconstruction
Not Applicable
Not yet recruiting
- Conditions
- Breast CancerBreast ReconstructionRadiation Oncology
- First Posted Date
- 2025-07-24
- Last Posted Date
- 2025-07-24
- Target Recruit Count
- 190
- Registration Number
- NCT07084519
- Locations
- 🇨🇳
Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Province, China
the Efficacy of MR-guided Online Adaptive Radiotherapy for Locally Advanced Rectal Cancer
Not Applicable
Not yet recruiting
- Conditions
- Rectal CancerAdaptive Radiotherapy
- First Posted Date
- 2025-07-23
- Last Posted Date
- 2025-07-23
- Target Recruit Count
- 49
- Registration Number
- NCT07080411
A Prospective Phase II Study of Postoperative Concurrent Chemoradiotherapy in Patients With Intrahepatic Cholangiocarcinoma
Not Applicable
Recruiting
- Conditions
- Intrahepatic Cholangiocarcinoma (Icc)Adjuvant ChemoradiotherapyNarrow MarginLymph Node Involvement
- First Posted Date
- 2025-07-14
- Last Posted Date
- 2025-07-14
- Target Recruit Count
- 66
- Registration Number
- NCT07063888
- Locations
- 🇨🇳
Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, China
- Prev
- 1
- 2
- 3
- 4
- 5
- 52
- Next
News
No news found